2008 |
Dotmatics has licensed to Lycera Corp Bishop's Stortford, 28th October 2008 Scientific software company Dotmatics Limited (Dotmatics) is pleased to announce that Lycera Corp (Lycera) has licensed Dotmatics' Vortex to facilitate data visualisation. |
|
Dotmatics Vortex featured in a review on "Macs in Chemistry" Dotmatics Vortex has been reviewed in an article by Chris Swain (Cambridge MedChem Consulting) featured in a review on "Macs in Chemistry" link to review. |
|
Dotmatics has licensed its product suite to Solace Pharmaceuticals Bishop's Stortford, 6th October 2008 Scientific software company Dotmatics is pleased to announce that Solace Pharmaceuticals (Solace) has licensed Dotmatics' software suite to facilitate information access and project management. Alex Leech, Executive Director at Solace, said: "We are delighted to be collaborating with Dotmatics - their software will allow us to create a central repository for research information so that we can easily query, browse and visualise data across our organisation." Bill Bailey, Global Account Manager at Dotmatics, said: "We are pleased to provide Solace with our fully integrated software package which comprehensively satisfies all of their informatics needs." |
|
Dotmatics has licensed its browser & pinpoint products to Arrow Therapeutics. Bishop's Stortford, 2nd May 2008 Scientific software company Dotmatics is pleased to announce that Arrow Therapeutics (Arrow) has licensed Dotmatics' browser & pinpoint software to facilitate information access and project management. The solution will be used by Arrow to query, browse, analyse and share key drug discovery information across research programs and project teams. Dr. Stuart Cockerill, Research Director at Arrow, said: "We are delighted to be working with Dotmatics, one of the leading providers of informatics systems. These tools will allow us to maximise the use of project data in our drug discovery processes." Dr Mike Hartshorn, CSO of Dotmatics, said: "We are pleased to provide Arrow with a fully integrated software package which easily operates alongside their current in-house informatics systems." |
|
Addex Pharmaceuticals have licensed browser & gateway Addex Pharmaceuticals has licensed the Dotmatics web-based browser & gateway suites to facilitate information access and project management. The solution will be used by Addex to query, browse, analyse and share key drug discovery information across research programs and project teams. Eric Gaillard, head of IT at Addex said: "The research process at Addex is dynamic, involving multiple internal and external groups. Part of my mission is to deliver on-demand real-time access to the latest incoming research information to managers. The Dotmatics gateway and browser complement our core research informatics framework and enable me to achieve this level of service." Steve Gallagher, CEO of Dotmatics said: "We are excited to have the opportunity to work with Addex Pharmaceuticals and look forward to a fruitful collaboration." |
|
University of Newcastle license the dotmatics suite of tools University of Newcastle license the dotmatics suite of tools for managing scientific documents, data and chemical information. Dr. Ian Hardcastle, Senior Lecturer in Medicinal Chemistry, Drug Development Section said "gateway and browser will allow us to efficiently manage the information generated by our Cancer Research UK funded drug discovery programme." |
2007 |
|
dotmatics expands into new premises dotmatics, a provider of information and data management solutions to the life sciences industry, is pleased to announce that on the 24th September 2007 it moved into its new offices. Stephen Gallagher, CEO of dotmatics said, "Moving the company to new premises allows us to continue to expand our support and development capability." |
|
Waters Corporation and dotmatics to collaborate Waters Corporation (NYSE:WAT) and dotmatics have signed an agreement to develop integrated advanced structure elucidation software to complement Waters time-of-flight (Tof) mass spectrometers and the Waters® Synapt™ and MALDI Synapt High Definition Mass Spectrometry™ (HDMS) Systems. The agreement will focus on developing a fully-integrated solution for structural elucidation of small molecules based on Dotmatics and Waters MassLynx™ MetaboLynx™ Application Manager software. "We are pleased to provide researchers with a fully integrated software package which is compatible with our innovative LC/MS/MS and LC/MS E data acquisition strategies that will allow scientists to interrogate fragmentation rich spectra and reduce the bottleneck in deciphering important molecular structures. The combination of Synapt HDMS System and this important collaboration will provide researchers with advanced tools for small molecule profiling," said Dr. Tim Riley, Vice-President and Managing Director, Pharmaceutical Business Operations, Waters Division. "We look forward to a fruitful collaboration with Waters Corporation" said Alastair Hill, Director and CTO at Dotmatics. "This agreement puts in place a framework to deliver novel software algorithms within the Waters MassLynx software platform which promises to result in huge time savings for scientists." |
|
Dotmatics joins BioIT Alliance community dotmatics has joined the Microsoft's BioIT Alliance community. The BioIT Alliance is a cross-industry group working to integrate science and technology to accelerate the pace of drug discovery and realize the potential of personalized medicine. "Our customers are looking for solutions that enable them to aggregate many forms of complex information and navigate through it effectively" said Don Rule, Platform Strategy Advisor for Bioinformatics at Microsoft. "We look forward to working with Dotmatics to provide scientists with richer and more integrated solutions." |
|
The Edge and dotmatics agree to co-promote software The Edge Software Consultancy (website), who provide informatics services to the drug discovery industry, and dotmatics have agreed to co-promote their software products. |
|
Drug Discovery Group at The University of Dundee license gateway, browser and pinpoint dotmatics have agreed a deal with the Drug Discovery Group at The University of Dundee to license gateway, browser and pinpoint. |
|
dotmatics appoints its new Sales & Marketing director dotmatics, a provider of information and data management solutions to the life sciences industry, today announced that it has appointed Jean Mercier as its new sales & marketing director, effective 7th December 2006. Upon accepting the role, Jean Mercier said: "Im thrilled at the idea of helping such a young and interesting scientific business develop..." |
2006 |
|
dotmatics launches new version of pinpoint chemical cartridge dotmatics Limited, a provider of informatics and data management solutions to the life sciences industry, today announced that it has released a new version of its chemical cartridge, pinpoint. Mike Hartshorn, CSO of dotmatics said "we were amazed at the performance improvements we found as we thought pinpoint was about as fast as you could get..." |
|
dotmatics appoints new CSO Mike Hartshorn, formerly of Astex Therapeutics joins dotmatics as CSO, effective 21st November 2006. Steve Gallagher, CEO of dotmatics said "we are delighted to have Mike as CSO, he brings with him years of experience and a wealth of knowledge." |
|
dotmatics hires two web programmers Due to expansion of the business and rapidly growing customer base, dotmatics has hired two web programmers. Alastair Hill, CTO of dotmatics said "this represents a significant investment in our committment to supporting our customers and further innovating our range of solutions." |
|
Gibson Index picks dotmatics as a 'Top SME' The Gibson Index, a UK-based national database of early stage technology companies, has picked dotmatics as a 'Top SME'. |
|
Astex and dotmatics sign collaboration agreement Astex, a UK-based biotechnology company producing novel small molecule therapeutics, has signed a software collaboration agreement with dotmatics. Under the terms of the agreement, Astex will license dotmatics" browser, gateway and eye software and dotmatics will exclusively license Astex's chemical structure searching software for further development and commercialisation as the product 'pinpoint'. Stephen Gallagher, CEO of dotmatics said, "we are very excited to have the opportunity to work with Astex and we look forward to a fruitful collaboration". Chris Murray, Director of Computational Chemistry and Informatics, at Astex said, "we are pleased to have signed this collaboration with dotmatics who are at the cutting edge of Informatics-based solutions to the pharma industry. We anticipate it will deliver enhancements to our Informatics set up and help drive productivity improvements at Astex." |
|
UCB licenses browser and gateway dotmatics has won a contract to provide the global biopharmaceutical company UCB with enterprise licenses to browser and gateway. By choosing dotmatics over other vendors, UCB has ensured that it has access to the most powerful, flexible and innovative software in the data querying/browsing/visualising and project management areas. |
|
Merck & Co. chooses dotmatics for decision management application dotmatics has won a contract with Merck & Co. to develop a bespoke decision management tool. dotmatics CTO, Alastair Hill, said "This represents a further strengthening of our relationship with Merck - we are pleased that they have again recognised our unique skills and experience in selecting us to develop this application.". |
|
BioFocus licenses gateway BioFocus DPI has acquired an enterprise license for gateway. They plan to use the system to manage collabroations both within their organisation and with external collaborators. |
|
Zyentia subscribes to eyeforscience Zyentia has taken out an enterprise subscription to eyeforscience, our hosted text-mining solution that provides access to literature, patents, grants, medical news, etc. through an easy to use web interface. Find out why - register for a free web demo. |
|
dotmatics moves to larger premises As part of our ongoing expansion program, dotmatics have moved into larger offices. Please consult our Contact Us page for details of our new postal address. |
|
dotmatics secures contract with J&J PRD dotmatics has secured a contract with Johnson & Johnson Pharmaceutical Research & Development, a division of Janssen Pharmaceutica NV. "This agreement is significant for dotmatics as it puts in place a framework for delivering software and consultancy services to a global healthcare provider over the coming years." said Dr. Stephen Gallagher, CEO of dotmatics. |
|
BioApproaches SW licenses eyeforscience BioApproaches South West has purchased a license to eyeforscience. They recognised the powerful business intelligence and analysis features that the system provides through its intuitive web interface. |
|
Collaborators at Cambridge University evaluate dotmatics software Cambridge University have begun an evaluation of dotmatics gateway software. They plan to use the system to allow researchers in different countries to work together - sharing results, documents, discussions etc with one another through an easy to use interface. If you think that your organisation could benefit by improving internal or external collaboration, then please do get in touch at info@dotmatics.com. |
|
dotmatics secures contract with major US pharmaceutical company dotmatics has secured a contract to deliver eye to a major US pharmaceutical company. The company also wanted to take advantage of our advanced web-aggregation, text analysis and mining capabilites. The customer believes the solution will change the way information is used for competitor intelligence and identification of licensing opportunities. Our solutions are applicable to small biotech and large pharmaceuticals companies alike. To find out how our solutions can help improve your business, please contact us at info@dotmatics.com. |
|
dotmatics signs partner agreement with Collexis B.V. dotmatics is pleased to announce that it has signed a partner agreement with Collexis B.V. The agreement allows dotmatics to embed the Collexis mining technology into interfaces for the life science industry. |
|
new look website This year we launched the new look dotmatics website. The aim was to simplify how our customers get to the key facts about our tools and services. We hope you like it. We welcome feedback of any kind, whether about the website or ideas for new tools and services we can provide. Please email all feedback to info@dotmatics.com. |
|
dotmatics incorporation Stephen Gallagher and Alastair Hill incorporated dotmatics Limited with the aim of delivering knowledge solutions to the life science industry. The company was founded on the basis of improving how companies in the industry store, manage, retrieve and analyse information. |
dotmatics NewsThings are moving fast here at dotmatics. Below are some of our recent highlights: |
